The Medibank Private Ltd (ASX: MPL) share price continues to enjoy the glow of the Coalition’s shock federal election victory with it up 15% over just the last month and up 33% over the past year. That’s some good growth for a company that has the amount it can put private healthcare premiums up by every year regulated by the federal government.
One reasons investors are probably bidding Medibank and NIB Holdings Ltd (ASX: NHF) shares higher is the belief that the Coalition government will encourage more people to take up private health insurance policies via increases to the Medicare levy or less generous spending on Medicare and its rebate system.
NIB shares are up around 15% since the election result and close to a 52-week high of $6.88.
Medibank offers investors some defensive revenues and dividends thanks to its reliable premiums paid by its huge amount of members.
At $3.33 the stock offers a trailing yield of 3.9% plus full franking credits based on 12.9 cents per share in dividends handed out over the past 12 months. On the same basis NIB’s trailing yield is 3.1% fully franked.
A little-known ASX company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.
And make no mistake – it is coming. To the tune of an estimated $US22 billion.
Cannabis legalisation is sweeping over North America, and full legalisation arrived in Canada in October 2018.
Here's the best part: we think there's one ASX stock that's uniquely positioned to profit immensely from this explosive new industry... taking savvy investors along for what could be one heck of a ride.
AND, this is the first time The Motley Fool Australia has EVER put a BUY recommendation on a marijuana stock.
Simply click below to learn more on how you can profit from the coming cannabis boom.
Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.